Under a trading plan, Stoke Therapeutics (STOK) medical chief sells 1,051 shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Stoke Therapeutics' Chief Medical Officer, Barry Ticho, sold 1,051 shares of common stock on October 1, 2026, at a weighted-average price of $26.1594 per share. This transaction was conducted under a Rule 10b5-1 trading plan adopted in November 2025. After the sale, Ticho directly held 19,059 shares.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.